221 related articles for article (PubMed ID: 27638585)
1. Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).
Bradbury AM; Bagel JH; Jiang X; Swain GP; Prociuk ML; Fitzgerald CA; O'Donnell PA; Braund KG; Ory DS; Vite CH
J Neurosci Res; 2016 Nov; 94(11):1007-17. PubMed ID: 27638585
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid and serum glycosphingolipid biomarkers in canine globoid cell leukodystrophy (Krabbe Disease).
Corado CR; Pinkstaff J; Jiang X; Galban EM; Fisher SJ; Scholler O; Russell C; Bagel JH; ODonnell PA; Ory DS; Vite CH; Bradbury AM
Mol Cell Neurosci; 2020 Jan; 102():103451. PubMed ID: 31794880
[TBL] [Abstract][Full Text] [Related]
3. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
4. Treatment for Krabbe's disease: Finding the combination.
Mikulka CR; Sands MS
J Neurosci Res; 2016 Nov; 94(11):1126-37. PubMed ID: 27638598
[TBL] [Abstract][Full Text] [Related]
5. Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.
Won JS; Singh AK; Singh I
J Neurosci Res; 2016 Nov; 94(11):990-1006. PubMed ID: 27638584
[TBL] [Abstract][Full Text] [Related]
6. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model.
Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL
Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and knockdown of galactocerebrosidase in zebrafish: new insights into the pathogenesis of Krabbe's disease.
Zizioli D; Guarienti M; Tobia C; Gariano G; Borsani G; Bresciani R; Ronca R; Giacopuzzi E; Preti A; Gaudenzi G; Belleri M; Di Salle E; Fabrias G; Casas J; Ribatti D; Monti E; Presta M
Biochim Biophys Acta; 2014 Apr; 1842(4):665-75. PubMed ID: 24463171
[TBL] [Abstract][Full Text] [Related]
8. Cellular transplant therapies for globoid cell leukodystrophy: Preclinical and clinical observations.
Maher KR; Yeager AM
J Neurosci Res; 2016 Nov; 94(11):1180-8. PubMed ID: 27638602
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of globoid cell leukodystrophy in Irish setters.
McGraw RA; Carmichael KP
Vet J; 2006 Mar; 171(2):370-2. PubMed ID: 16490723
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
11. Globoid cell leukodystrophy (Krabbe's disease): update.
Suzuki K
J Child Neurol; 2003 Sep; 18(9):595-603. PubMed ID: 14572137
[TBL] [Abstract][Full Text] [Related]
12. AAVrh10 Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease).
Bradbury AM; Rafi MA; Bagel JH; Brisson BK; Marshall MS; Pesayco Salvador J; Jiang X; Swain GP; Prociuk ML; ODonnell PA; Fitzgerald C; Ory DS; Bongarzone ER; Shelton GD; Wenger DA; Vite CH
Hum Gene Ther; 2018 Jul; 29(7):785-801. PubMed ID: 29316812
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy.
Feltri ML; Weinstock NI; Favret J; Dhimal N; Wrabetz L; Shin D
Glia; 2021 Oct; 69(10):2309-2331. PubMed ID: 33851745
[TBL] [Abstract][Full Text] [Related]
14. Immunological considerations for treating globoid cell leukodystrophy.
Karumuthil-Melethil S; Gray SJ
J Neurosci Res; 2016 Nov; 94(11):1349-58. PubMed ID: 27638617
[TBL] [Abstract][Full Text] [Related]
15. Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.
Jang DS; Ye W; Guimei T; Solomon M; Southall N; Hu X; Marugan J; Ferrer M; Maegawa GH
J Neurosci Res; 2016 Nov; 94(11):1231-45. PubMed ID: 27638606
[TBL] [Abstract][Full Text] [Related]
16. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
[TBL] [Abstract][Full Text] [Related]
17. Globoid cell leukodystrophy in cairn and West Highland white terriers.
Wenger DA; Victoria T; Rafi MA; Luzi P; Vanier MT; Vite C; Patterson DF; Haskins MH
J Hered; 1999; 90(1):138-42. PubMed ID: 9987921
[TBL] [Abstract][Full Text] [Related]
18. Krabbe disease successfully treated via monotherapy of intrathecal gene therapy.
Bradbury AM; Bagel JH; Nguyen D; Lykken EA; Pesayco Salvador J; Jiang X; Swain GP; Assenmacher CA; Hendricks IJ; Miyadera K; Hess RS; Ostrager A; ODonnell P; Sands MS; Ory DS; Shelton GD; Bongarzone ER; Gray SJ; Vite CH
J Clin Invest; 2020 Sep; 130(9):4906-4920. PubMed ID: 32773406
[TBL] [Abstract][Full Text] [Related]
19. Myelin repair by transplantation of myelin-forming cells in globoid cell leukodystrophy.
Kondo Y; Duncan ID
J Neurosci Res; 2016 Nov; 94(11):1195-202. PubMed ID: 27557886
[TBL] [Abstract][Full Text] [Related]
20. Murine, canine and non-human primate models of Krabbe disease.
Wenger DA
Mol Med Today; 2000 Nov; 6(11):449-51. PubMed ID: 11074371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
